Background: Adipose tissue dysfunction has been implicated in the pathophysiology of
Alzheimer's disease. However, the involvement of adipokines, particularly adiponectin …

Background: The association between dementia and serum adiponectin has been
evaluated in many studies; however, conclusions remain mixed. Objective: We investigated …

Adiponectin is an adipokine playing a central role in the regulation of energy homeostasis,
carbohydrate and lipid metabolism, as well as immunomodulation. The relationship between …

Background and purpose: Life style‐related disorders such as hypertension, diabetes,
dyslipidemia, and obesity are reported to be a great risk of dementia. Adipocytokines …

Adiponectin, an adipocytokine released by the adipose tissue and has important roles in the
metabolic regulation and inflammatory control, may play an important roles in the …

Background: Adiponectin, a protein involved in inflammatory pathways, may impact the
development and progression of Alzheimer's disease (AD). Adiponectin levels have been …

Background The role of adiponectin (ADIPOQ) in Alzheimer's disease (AD) has been
documented, however, demonstrating controversial results. In this study, we investigated …

Background: Although peripheral blood adipokines and insulin levels have been considered
to be biomarkers of Alzheimer's disease (AD), previous researches about levels of …

Background Blood adiponectin and leptin are adipokines that emerged as potential
biomarkers for predicting Alzheimer's disease (AD) owing to their strong connection with …

Adiponectin is an adipocyte-derived peptide that increases with age and is thought to protect
against atherosclerotic vascular changes and organ damage. However, paradoxically …